Change search
ReferencesLink to record
Permanent link

Direct link
Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin Z(HER2:2891)-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain
KTH, School of Biotechnology (BIO), Protein Technology.
KTH, School of Biotechnology (BIO), Protein Technology.
Show others and affiliations
2015 (English)In: International Journal of Oncology, ISSN 1019-6439, Vol. 47, no 2, 601-609 p.Article in journal (Refereed) Published
Abstract [en]

Development of cancer treatment regimens including immunotoxins is partly hampered by their immunogenicity. Recently, deimmunized versions of toxins have been described, potentially being better suited for translation to the clinic. In this study, a recombinant tripartite fusion toxin consisting of a deimmunized version of exotoxin A from Pseudomonas aeruginosa (PE38) genetically fused to an affibody molecule specifically interacting with the human epidermal growth factor receptor 2 (HER2), and also an albumin binding domain (ABD) for half-life extension, has been produced and characterized in terms of functionality of the three moieties. Biosensor based assays showed that the fusion toxin was able to interact with human and mouse serum albumin, but not with bovine serum albumin and that it interacted with HER2 (K-D=5 nM). Interestingly, a complex of the fusion toxin and human serum albumin also interacted with HER2 but with a somewhat weaker affinity (K-D=12 nM). The IC50-values of the fusion toxin ranged from 6 to 300 pM on SKOV-3, SKBR-3 and A549 cells and was lower for cells with higher surface densities of HER2. The fusion toxin was found specific for HER2 as shown by blocking available HER2 receptors with free affibody molecule before subjecting the cells to the toxin. Analysis of contact time showed that 10 min was sufficient to kill 50% of the cells. In conclusion, all three regions of the fusion toxin were found to be functional.

Place, publisher, year, edition, pages
2015. Vol. 47, no 2, 601-609 p.
Keyword [en]
affibody molecule, immunotoxin, albumin binding domain, PE38, HER2
National Category
Cancer and Oncology
URN: urn:nbn:se:kth:diva-171879DOI: 10.3892/ijo.2015.3027ISI: 000357965700022ScopusID: 2-s2.0-84932646862OAI: diva2:846450
Swedish Cancer Society

QC 20150817

Available from: 2015-08-17 Created: 2015-08-10 Last updated: 2015-08-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Liu, HaoSeijsing, JohanGräslund, Torbjörn
By organisation
Protein Technology
In the same journal
International Journal of Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 58 hits
ReferencesLink to record
Permanent link

Direct link